Bacterial β-glucuronidase inhibition protects mice against enteropathy induced by indomethacin, ketoprofen or diclofenac: mode of action and pharmacokinetics

References

• Balani SK, Li P, Nguyen J, et al. (2004). Effective dosage regimen of 1-aminobenzotriazole for inhibition of antipyrene clearance in guinea pigs and mice using serial sampling. Drug Metab Disp 32:1092–5
   PubMed Web of Science ®Google Scholar
• Bjarnason I. (2013). Gastrointestinal safety of NSAIDs and over-the-counter analgesics. Int J Clin Pract 67:37–42
   Web of Science ®Google Scholar
• Boelsterli UA, Redinbo MR, Saitta K. (2013). Multiple NSAID-induced hits injure the small intestine: underlying mechanisms and novel strategies. Toxicol Sci 131:654–67
   PubMed Web of Science ®Google Scholar
• Caldwell GW, Ritchie DM, Masucci JA, et al. (2005). The use of the suicide CYP450 inhibitor ABT for distinguishing absorption and metabolism processes in in-vivo pharmacokinetic screens. Eur J Drug Metab Pharmacokinet 30:75–83
   PubMed Web of Science ®Google Scholar
• Colombo F, Armstrong C, Duan J, Rioux N. (2012). A high throughput in vitro mrp2 assay to predict in vivo biliary excretion. Xenobiotica 42:157–63
   PubMed Web of Science ®Google Scholar
• Dial EJ, Darling RL, Lichtenberger LM. (2008). Importance of biliary excretion of indomethacin in gastrointestinal and hepatic injury. J Gastroenterol Hepatol 23:e384–9
   Google Scholar
• Duggan DE, Hooke KF, Noll RM, Kwan KC. (1975). Enterohepatic circulation of indomethacin and its role in intestinal irritation. Biochem Pharmacol 25:1749–54
   Web of Science ®Google Scholar
• Evans AM. (1992). Enantioselective pharmacodynamics and pharmacokinetics of chiral non-steroidal anti-inflammatory drugs. Eur J Clin Pharmacol 42:237–56
   PubMed Web of Science ®Google Scholar
• Fujimoto K, Kumagai K, Ito K, et al. (2009). Sensitivity of liver injury in heterozygous Sod2 knockout mice treated with troglitazone or acetaminophen. Toxicol Pathol 37:193–200
   PubMed Web of Science ®Google Scholar
• Fukumoto K, Naito Y, Takagi T, et al. (2011). Role of tumor necrosis factor-α in the pathogenesis of indomethacin-induced small intestinal injury in mice. Int J Molec Med 27:353–9
   PubMed Web of Science ®Google Scholar
• Ju C, Uetrecht J. (1998). Oxidation of a metabolite of indomethacin (desmethyldeschlorobenzoylindomethacin) to reactive intermediates by activated neutrophils, hypochlorous acid, and the myeloperoxidase system. Drug Metab Disp 26:676–80
   PubMed Web of Science ®Google Scholar
• Julou L, Guyonnet JC, Ducrot R, et al. (1976). Ketoprofen (19.583 R.P.) (2-(3-benzoylphenyl)-propionic acid). Main pharmacological properties – outline of toxicological and pharmacokinetic data. Scand J Rheumatol suppl. 14:33–44
   Google Scholar
• Kirman CR, Sweeney LM, Meek ME, Gargas ML. (2005). Assessing the dose-dependency of allometric scaling performance using physiologically based pharmacokinetic modeling. Reg Toxicol Pharmacol 38:345–67
   Google Scholar
• Kretz-Rommel A, Boelsterli U. (1993). Diclofenac covalent protein binding is dependent on acyl glucuronide formation and is inversely related to acute cell injury in cultured rat hepatocytes. Toxicol Appl Pharmacol 120:155–61
   PubMed Web of Science ®Google Scholar
• Lim MS, Lim PLK, Gupta R, Boelsterli UA. (2006). Critical role of free cytosolic calcium, but not uncoupling, in mitochondrial permeability transition and cell death induced by diclofenac oxidative metabolites in immortalized human hepatocytes. Toxicol Appl Pharmacol 217:322–31
   PubMed Web of Science ®Google Scholar
• LoGuidice A, Wallace BD, Bendel L, et al. (2012). Pharmacologic targeting of bacterial β-glucuronidase alleviates nonsteroidal anti-inflammatory drug-induced enteropathy in mice. J Pharmacol Exp Ther 341:447–54
   PubMed Web of Science ®Google Scholar
• Nezasa K, Tian X, Zamek-Gliszczynski MJ, et al. (2006). Altered hepatobiliary disposition of 5 (and 6)-carboxy-2′,7′-dichlorofluorescein in Abcg2 (Bcrp1) and Abcc2 (Mrp2) knockout mice. Drug Metab Disp 34:718–23
   PubMed Web of Science ®Google Scholar
• Ramirez-Alcantara V, LoGuidice A, Boelsterli UA. (2009). Protection from diclofenac-induced small intestinal injury by the JNK inhibitor SP600125 in a mouse model of NSAID-associated enteropathy. Am J Physiol (Gastrointest Liver Physiol) 297:G990–8
   Google Scholar
• Reuter BK, Wallace JL. (1999). Phosphodiesterase inhibitors prevent NSAID enteropathy independently of effects on TNF-α release. Am J Physiol (Gastrointest Liver Physiol) 40:G847–54
   Google Scholar
• Sarda S, Page C, Pickup K, et al. (2012). Diclofenac metabolism in the mouse: novel in vivo metabolites identified by high performance liquid chromatography coupled to linear ion trap mass spectrometry. Xenobiotica 42:179–94
   PubMed Web of Science ®Google Scholar
• Scarpignato C, Hunt RH. (2010). Nonsteroidal antiinflammatory drug-related injury to the gastrointestinal tract: clinical picture, pathogenesis, and prevention. Gastroenterol Clin N Am 39:433–64
   PubMed Web of Science ®Google Scholar
• Seitz S, Boelsterli UA. (1998). Diclofenac acyl glucuronide, a major biliary metabolite, is directly involved in small intestinal injury in rats. Gastroenterology 115:1476–82
   PubMed Web of Science ®Google Scholar
• Seitz S, Kretz-Rommel A, Oude Elferink RPJ, Boelsterli UA. (1998). Selective protein adduct formation of diclofenac glucuronide is critically dependent on the rat canalicular conjugate export pump (Mrp2). Chem Res Toxicol 11:513–19
   PubMed Web of Science ®Google Scholar
• Wallace BD, Wang H, Lane KT, et al. (2010). Alleviating cancer drug toxicity by inhibiting a bacterial enzyme. Science 330:831–5
   PubMed Web of Science ®Google Scholar
• Wallace JL. (2012). NSAID gastropathy and enteropathy: distinct pathogenesis likely necessitates distinct prevention strategies. Br J Clin Pharmacol 165:67–74
   Google Scholar
• Wilson ID, Nicholson JK. (2009). The role of gut microbiota in drug response. Curr Pharmaceut Design 15:1519–23
   PubMed Web of Science ®Google Scholar
• Yoriki H, Naito Y, Takagi T, et al. (2012). Hemin ameliorates indomethacin-induced small intestinal injury in mice through the induction of heme oxygenase-1. J Gastroenterol Hepatol 28:632–8
   Google Scholar
• Zamek-Gliszczynski MJ, Xiong H, Patel NJ, et al. (2003). Pharmacokinetics of 5 (and 6)-carboxy-2′,7′-dichlorofluorescein and its diacetate promoiety in the liver. J Pharmacol Exp Ther 304:801–9
   PubMed Web of Science ®Google Scholar
• Zhu Y, Zhang QY. (2012). Role of intestinal cytochrome P450 enzymes in diclofenac-induced toxicity in the small intestine. J Pharmacol Exp Ther 343:362–70
   PubMed Web of Science ®Google Scholar